display

US President Joe Biden has welcomed the emergency approval for the corona vaccine from US corporation Johnson & Johnson in the United States as an important step in coping with the pandemic.

Biden spoke on Saturday evening of "exciting news for all Americans and an encouraging development in our endeavors to end the crisis".

The emergency approval previously granted by the US FDA is no reason to give the all-clear, even if there is “light at the end of the tunnel”.

It is crucial to vaccinate as many people as possible as quickly as possible and to continue to comply with distance and hygiene rules.

The FDA conditionally approved Johnson & Johnson's corona vaccine on Saturday.

This means that - after the vaccines from the Mainz-based pharmaceutical company Biontech and its US partner Pfizer, as well as the US pharmaceutical company Moderna - there is now a third corona vaccine on the US market.

The preparation from Johnson & Johnson unfolds its full effect after administration of one dose and - unlike the other vaccines used - does not have to be injected twice.

At the beginning of February, Johnson & Johnson applied to the FDA for emergency approval for the corona vaccine developed by its pharmaceuticals division.

The application to the EU Medicines Agency EMA followed in mid-February.

The EMA said it would test the vaccine from Johnson & Johnson subsidiary Janssen-Cilag International NV in an accelerated process.

The committee responsible could give its assessment in mid-March.

All developments in the live ticker